Cardinal Health Sees Remarkable Growth in First Quarter
Cardinal Health Inc. (NYSE: CAH) recently celebrated a significant rise in its stock price, driven by impressive financial results for the first quarter of 2026. The company reported adjusted earnings of $2.55 per share, which exceeded expectations, with the consensus set at $2.18.
Revenue Rise and Solid Segments Performance
The revenue figures are equally encouraging, revealing a 22% increase year over year, amounting to $64.01 billion. This number also surpassed analysts' expectations, which were around $59.19 billion.
In particular, the Pharmaceutical and Specialty Solutions segment had a stellar performance, generating $59.2 billion, marking a 23% growth, thanks to the strong sales of brand and specialty pharmaceuticals from its extensive customer base.
Additionally, the Global Medical Products and Distribution segment increased 2%, bringing in $3.2 billion, with growth attributed to existing customer volume increases.
Share Repurchase Announcement
To further enhance shareholder value, Cardinal Health announced the initiation of a $375 million accelerated share repurchase program in this quarter.
CEO's Insights and Future Expectations
CEO Jason Hollar expressed optimism about the future: "This outstanding first quarter reflects our focused execution across each of our operating segments and provides a solid foundation as we carry forward. We are raising our fiscal 2026 outlook due to this strong performance."
Raising the Fiscal Outlook
Owing to these impressive results, Cardinal Health has revised its outlook for fiscal year 2026. The adjusted earnings per share forecast has been raised from a range of $9.30-$9.50 to $9.65-$9.85, surpassing the market consensus of $9.43 per share.
This upward revision of $0.35 indicates the company’s confidence in its ongoing success and reflects anticipated contributions from strategic moves, including the recent acquisition of Solaris Health.
Profit growth expectations for the Pharmaceutical and Specialty Solutions segment have been improved to 16%-19%, up from the previous range of 11%-13%.
Moreover, Cardinal Health has also increased its adjusted free cash flow projections to between $3.0 billion and $3.5 billion, compared to its earlier prediction of $2.75 billion to $3.25 billion.
Current Market Status
At the time of reporting, Cardinal Health's stock was observed trading higher, boasting a 16.55% increase to $191.68, reflecting investor confidence in the company’s future potential and steady growth trajectory.
Frequently Asked Questions
What were Cardinal Health's adjusted earnings per share for Q1 2026?
Cardinal Health reported adjusted earnings of $2.55 per share for the first quarter of 2026.
How much did Cardinal Health's revenue increase year over year in Q1 2026?
Cardinal Health's revenue increased by 22% year over year, reaching $64.01 billion.
What actions is Cardinal Health taking to enhance shareholder value?
The company has initiated a $375 million accelerated share repurchase program to increase shareholder value.
What is the new outlook for Cardinal Health's adjusted earnings for fiscal 2026?
The outlook for adjusted earnings per share has been increased to $9.65-$9.85 for fiscal 2026.
What is the current stock price of Cardinal Health as per the latest report?
The stock price of Cardinal Health is currently trading at $191.68, reflecting a gain of 16.55%.
